US 11339213
Methods and compositions for treatment of cancer
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 11339213 (Methods and compositions for treatment of cancer) held by MEREO BIOPHARMA 5, INC. expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- MEREO BIOPHARMA 5, INC.
- Grant date
- Tue May 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 36
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K31/282, A61K31/337